Table 2.
Parameters of the general model with their description.
| parameter | description |
|---|---|
| β | baseline transmission rate (for the sensitive infection) |
| δO | transmissibility of treated sensitive infection with oseltamivir relative to untreated infection |
| δZ | transmissibility of treated sensitive infection with zanamivir relative to untreated infection |
| δA | transmissibility of asymptomatic infection relative to symptomatic infection |
| δr,O | transmissibility of oseltamivir-resistant strain relative to the sensitive strain |
| δr,Z | transmissibility of zanamivir-resistant strain relative to the sensitive strain |
| fs | fraction of exposed individuals that develops symptoms |
| fT | fraction of symptomatic infections that is treated |
| fO | fraction of treated infections that receives oseltamivir |
| ρO | rate of developing de novo resistance to oseltamivir |
| ρZ | rate of developing de novo resistance to zanamivir |
| 1/μE | mean duration of latency |
| 1/μA | mean duration of asymptomatic infection |
| 1/μ | mean duration of symptomatic infection |